NeuroVigil's non-invasive iBrain™ Personal Brain Monitor launched in 4 US states, raising $85M in Series B financing, valuing the company at over $6B.
NeuroVigil, a Silicon Valley-based neurotechnology company, has launched its non-invasive iBrain™ Personal Brain Monitor in four US states. The company sold 1.4% of its stock for $85M, valuing it at over $6B, making it the highest Series B financing in history. The $4.5B margin over Facebook's Series B valuation was achieved through support from 27 strategic investors, including hospitals, universities, and law firms, who favored non-invasive brain technology. The invitation-only financing closed in 24 minutes.
April 05, 2024
9 Articles